Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read MorePosted by Steve Halasey | Jul 2, 2018 | Cancer, Molecular Diagnostics, Research, Specimen Collection & Handling |
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read MorePosted by Steve Halasey | Jul 2, 2018 | Flow Cytometry, Research |
The companies will provide a comprehensive offering for the development of companion diagnostics, from biomarker discovery through regulatory approval and commercialization.
Read MorePosted by Steve Halasey | Jul 2, 2018 | Research |
Qiagen’s partnership with artificial intelligence genomics company Freenome seeks to accelerate NGS tests and advance precision medicine for cancer treatment.
Read MorePosted by Steve Halasey | Jul 2, 2018 | Research |
For women who test negative for hereditary breast cancer mutations, the RiskScore test predicts 5-year and lifetime risk of breast cancer.
Read MorePosted by Steve Halasey | Jul 2, 2018 | Research |
Study finds improvements in remission, response, and symptoms for patients with major depression whose medication selection was guided by GeneSight testing.
Read More